Glycorex Transplantation Overview

  • Founded
  • 1996

Founded
  • Status
  • Public

  • Employees
  • 22

Employees
  • Stock Symbol
  • GTAB B

Stock Symbol
  • Share Price
  • $0.40

  • (As of Friday Closing)

Glycorex Transplantation General Information

Description

Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Contact Information

Website
www.glycorex.se
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Stock Exchange
NGM
Primary Office
  • Scheelevägen 27
  • 223 63 Lund
  • Sweden
+46 046-286 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycorex Transplantation Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.40 $0.40 $0.36 - $1.17 $29.8M 73.9M 33.6K -$0.02

Glycorex Transplantation Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 41,227 71,996 99,022 77,351
Revenue 3,629 3,284 2,928 3,817
EBITDA (175) (405) (57) 1,310
Net Income (1,133) (1,426) (872) 730
Total Assets 9,298 11,249 13,738 9,181
Total Debt 786 1,000 1,139 1,532
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Glycorex Transplantation Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Glycorex Transplantation‘s full profile, request access.

Request a free trial

Glycorex Transplantation Patents

Glycorex Transplantation Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3762716-A4 A protein-binding product, a device contaning said protein-binding product and a method for extracorporeal reduction of the level of protein in blood plasma Pending 08-Mar-2018 00000000000
EP-3762716-A1 A protein-binding product, a device contaning said protein-binding product and a method for extracorporeal reduction of the level of protein in blood plasma Pending 08-Mar-2018 00000000000
US-20200406230-A1 A protein-binding product, a device containing said protein-binding product and a method for extracorporeal reduction of the level of protein in blood plasma Pending 08-Mar-2018 00000000000
US-20140255409-A1 Method for extracorporeal elimination of one or more components from blood Inactive 28-Oct-2011 00000000000
EP-2771087-A1 A method for extracorporeal elimination of one or more components from blood Inactive 28-Oct-2011 B01D15/3804
To view Glycorex Transplantation’s complete patent history, request access »

Glycorex Transplantation Executive Team (3)

Name Title Board Seat Contact Info
Johan Nilsson Interim Chief Executive Officer
Kurt Nilsson Founder & Chairman
You’re viewing 2 of 3 executive team members. Get the full list »

Glycorex Transplantation Board Members (1)

Name Representing Role Since
0000 0000000 Glycorex Transplantation Founder & Chairman 000 0000
To view Glycorex Transplantation’s complete board members history, request access »

Glycorex Transplantation Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial